Stevens Capital Management LP Alnylam Pharmaceuticals, Inc. Transaction History

Stevens Capital Management LP

  • $703 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$146.51 - $198.2 $203,648 - $275,498
1,390 New
1,390 $208,000
Q3 2019

Nov 08, 2019
SELL
$70.9 - $87.82 $1.03 Million - $1.28 Million
-14,571 Closed
0 $0
Q2 2019

Jul 31, 2019
BUY
$65.86 - $92.79 $959,646 - $1.35 Million
14,571 New
14,571 $1.06 Million
Q4 2018

Feb 06, 2019
SELL
$62.67 - $88.33 $441,259 - $621,931
-7,041 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$87.52 - $122.67 $616,228 - $863,719
7,041 New
7,041 $616,000

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $28.8B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Stevens Capital Management LP Portfolio

Follow Stevens Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Stevens Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email